Harvard Medical School, Treatment Innovations, 28 Westbourne Road, Newton Centre, MA 02459, USA.
J Gambl Stud. 2010 Dec;26(4):583-92. doi: 10.1007/s10899-010-9179-z.
This paper represents the first study of treatment utilization among pathological gamblers with and without PTSD. Comorbidity of PG and PTSD is increasingly recognized as an important association, both in its rate and clinical severity. The sample comprised 106 adults from the community (35 with current PG; 36 with current PTSD, and 35 with BOTH). Four areas were addressed: current treatment utilization, lifetime treatment utilization, specific treatments utilized, and satisfaction with treatments. Results indicated that the presence of PTSD was associated with higher treatment utilization (for current utilization, PTSD was higher than PG; and for lifetime, PTSD and PTSD/PG were both higher than PG). Indeed, only a minority of the PG group had ever attended current or lifetime treatment, whereas the majority of PTSD and PTSD/PG had. Yet notably, those with PG who utilized current treatment had no less satisfaction, number of treatment types, nor number of days in treatment than the other two groups. For all three groups, the most common current treatments were individual therapy and psychiatric medications. Study strengths include a rigorously diagnosed sample; an extensive interview-based assessment of treatment utilization, and identification of both current and lifetime utilization. Limitations include the inability to explore change over time or test-retest reliability of responses.
本文是第一份研究病理性赌博者和创伤后应激障碍（PTSD）患者治疗利用情况的研究报告。PG 和 PTSD 的共病现象，无论是在其发病率还是在临床严重程度方面，都被越来越多地认为是一种重要的关联。该样本包括来自社区的 106 名成年人（35 名当前患有 PG；36 名当前患有 PTSD，35 名同时患有 PG 和 PTSD）。研究涵盖了四个方面：当前治疗的利用情况、终生治疗的利用情况、具体治疗的利用情况以及对治疗的满意度。结果表明，PTSD 的存在与更高的治疗利用率相关（当前利用率方面，PTSD 高于 PG；终生利用率方面，PTSD 和 PTSD/PG 均高于 PG）。事实上，PG 组中只有少数人曾经接受过当前或终生治疗，而 PTSD 和 PTSD/PG 组中的大多数人都接受过治疗。然而值得注意的是，那些接受当前治疗的 PG 患者在治疗满意度、治疗类型数量和治疗天数方面与其他两组没有差异。对于所有三组患者，当前最常见的治疗方法是个体治疗和精神科药物治疗。研究的优势包括：严格诊断的样本；对治疗利用情况进行了广泛的访谈式评估，并确定了当前和终生的治疗利用情况。研究的局限性包括无法探索时间变化或反应的测试-重测信度。
